Basophils are found to be key drivers of allergy-induced lung inflammation

Figure 1: Lung inflammation that causes asthma is linked to the secretion of interleukin-4 (IL-4) from immune cells called basophils. Credit: Elsevier

Many particles and molecules in the environment can trigger allergic asthma in susceptible individuals. The allergic response to some of these allergens results in lung inflammation that can lead to a narrowing of the airways and even severe respiratory difficulty. A research team led by Masato Kubo from the RIKEN Center for Integrative Medical Sciences has now identified that a type of immune cell called a basophil is responsible for initiating a cascade of events that leads to inflammation of the lung in mice after exposure to plant- and dust-mite-derived allergens.

Protein-chewing enzymes known as proteases that are derived from dust mites and plants can begin to break down cells in the outer layer of the lung, causing damage that can initiate a local inflammatory reaction. While investigating the triggers of this inflammation, the researchers found that these protease induced in normal mice with a complete immune system, but not in mice genetically engineered to lack basophils.

Immune cells, including basophils, secrete the cytokine interleukin-4 (IL-4), which is known to play a role in the induction of . The extent to which basophil-derived IL-4 is involved in the induction of lung inflammation, however, was unknown. Kubo and his colleagues showed that proteases could increase the expression of IL-4 in basophils but not in other types of immune cells. In mice whose basophils were unable to produce IL-4, protease treatment did not cause lung inflammation, suggesting that basophil-derived IL-4 could be the main driver of protease-allergen-induced asthma in mice—a finding that could also extend to humans.

Natural helper (NH) cells are another type of immune cell that is known to play a role in the body's response to allergens. The researchers showed that NH cells express the receptor for IL-4, and that NH cells treated with IL-4 increase their expression of cytokines such as IL-5 and IL-3, which are also known to be involved in asthma induction. IL-4-treated NH cells also demonstrate a rise in expression of various chemokine proteins known to attract large numbers of eosinophil to the lung (Fig. 1). This influx of eosinophils triggers inflammation and narrowing of the airway, which leads to asthmatic symptoms such as wheezing.

"The findings suggest that treatments that reduce the numbers of basophils, or that prevent the production of IL-4 by basophils, could be promising for the management of lung and asthma caused by protease allergens," says Kubo.

More information: Motomura, Y., Morita, H., Moro, K., Nakae, S., Artis, D., Endo, T. A., Kuroki, Y., Ohara, O., Koyasu, S. & Kubo, M. "Basophil-derived interleukin-4 controls the function of natural helper cells, a member of ILC2s, in lung inflammation." Immunity 40, 758–771 (2014). DOI: 10.1016/j.immuni.2014.04.013

add to favorites email to friend print save as pdf

Related Stories

Fighting asthma drug resistance

Jan 10, 2014

Current asthma treatments include drugs that open up the tubes of the lungs and corticosteroids that fight lung inflammation. Some patients, however, are stubbornly resistant to corticosteroids, limiting ...

Hope of new treatment for severe asthma patients

Oct 25, 2013

New research from Japan brings hope of a new treatment for asthma patients resistant to corticosteroids. In a study published today in the journal Nature Communications, researchers from the RIKEN Center ...

Slowing down the immune system when in overdrive

Feb 10, 2014

Many people suffer from chronic inflammation because their immune systems overreact to 'self' tissue. Sydney scientists believe that a small molecule known as Interleukin 21 is a promising therapeutic target in such cases.

A treatment for obesity-associated asthma

Dec 16, 2013

(Medical Xpress)—Research conducted at Boston Children's Hospital indicates that obesity might cause asthma via factors in the immune system and suggests a new way of treating asthma in obese people—who often respond ...

Recommended for you

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.